|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1101 17th Street, NW |
Address2 | Suite 500 |
City | Washington |
State | DC |
Zip Code | 20036 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Yonkers |
State | NY |
Zip Code | 10703 |
Country | USA |
|
5. Senate ID# 10651-12
|
||||||||
|
6. House ID# 318070000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Theresa Thomas, Office Administrator |
Date | 07/29/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BAN
16. Specific lobbying issues
HR 5244, Credit Cardholders' Bill of Rights Act of 2008.
S 2452, Home Ownership Preservation and Protection Act of 2007.
HR 946, Consumer Overdraft Protection Fair Practices Act.
S 2753, Credit Card Reform Act of 2008.
Issues related to banking and financial privacy.
Issues related to payday loans.
Issues related to credit card reform.
Issues related to security freeze.
Issues related to overdraft loans.
Issues related to student financial aid.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ellen |
Bloom |
|
|
|
Jeannine |
Kenney |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
S 2663, CPSC Reform Act, issues related to CPSC funding.
HR 4040, Consumer Product Safety Modernization Act.
S 2045, CPSC Reform Act of 2007, issues related to CPSC funding.
HR 3610, Food and Drug Import Safety Act of 2007.
HR 5244, Credit Cardholders' Bill of Rights Act of 2008.
HR 946, Consumer Overdraft Protection Fair Practices Act.
S 2753, Credit Card Reform Act of 2008.
HR 882, Access to Emergency Medical Services Act of 2007.
HR 1174, Healthy Hospitals Act of 2007.
HR 4214, Community and Healthcare-Associated Infections Reduction Act of 2007.
MRSA legislation.
Issues related to Medicare Part D reform.
Issues related to product safety, food safety, and toy safety.
Issues related to credit card reform.
Issues related to the racial disparity study.
Issues related to the quality of health technology.
Issues related to the cloned food ruling.
Issues related to salmon labeling/codex fish labeling.
Issues related to the whistleblower protection product recall effectiveness.
Issues related to garage door operators.
Issues related to crib saftey.
Issues related to kids and cars.
Issues related to drug import safety.
Issues related to the DTV transition.
Issues related to lending reform.
Issues related to security freeze.
Issues related to overdraft loans.
Issues related to medicare low income assistance.
Issues related to emergency room reform.
Issues related to cell phone reform auto safety.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Federal Communications Commission (FCC), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Baker-Branstetter |
|
|
|
Ellen |
Bloom |
|
|
|
Ami |
Gadhia |
|
|
|
Joel |
Kelsey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIN
16. Specific lobbying issues
HR 5244, Credit Cardholders' Bill of Rights Act of 2008.
S 2452, Home Ownership Preservation and Protection Act of 2007.
S 2753, Credit Card Reform Act of 2008.
HR 946, Consumer Overdraft Protection Fair Practices Act.
Issues related to banking and financial privacy.
Issues related to credit card reforms.
Issues related to data privacy.
Issues related to ID theft.
Issues related to the credit card industry practices.
Issues related to predatory lending.
Issues related to security freeze.
Issues related to overdraft loans.
Issues related to lending reform.
Issues related to student financial aid.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeannine |
Kenney |
|
|
|
Ellen |
Bloom |
|
|
|
Eugene |
Kimmelman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
HR 2419, Farm Bill Extension Act of 2007.
HR 3610, Food and Drug Import Safety Act of 2007.
Issues related to food safety.
Issues related to cloned food.
Issues related to salmon labeling/codex fish labeling.
Issues related to imported fish safety.
Issues related to GMO fish labeling.
Issues related to meat recall secrecy.
Issues related to raised label standards.
Issues related to green marketing claims.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ellen |
Bloom |
|
|
|
Ami |
Gadhia |
|
|
|
Eugene |
Kimmelman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to health technology and quality.
Issues related to comparative effectiveness.
Issues related to emergency room reform.
Issues related to drug import safety.
Issues related to medicare low income assistance.
Issues related to e-prescribing.
MRSA legislation.
Issues related to the Medicare Part D reform.
Issues related to the Sunshine Act.
Issues related to the Medtronic Fix.
Issues related to antibiotic resistance.
Issues related to anti-steroid legislation.
Issues related to medicaid assistance.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Baker-Branstetter |
|
|
|
Ellen |
Bloom |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
HR 1174, Healthy Hospitals Act of 2007.
S 2278, Community and Healthcare-Associated Infections Reduction Act of 2007.
HR 3162, Children's Health and Medicare Protection Act of 2007.
HR 4214, Community and Healthcare-Associated Infections Reduction Act of 2007.
S 2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007.
Issues related to hospital infections.
Issues related to health technology and quality.
Issues related to e-prescribing.
Issues related to anitbiotic resistance.
MRSA legislation.
Issues related to emergency room reform.
Issues related to anti-steroid legislation.
Issues related to comparative effectiveness.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Agency for Health Care Policy & Research
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ellen |
Bloom |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 3162, Children's Health and Medicare Protection Act of 2007.
HR 882, Access to Emergency Medical Services Act of 2007.
S 2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007.
Issues related to Medicare Part D Reform.
Issues related to medicare low income assistance.
Issues related to medicaid assistance in the federal relief package.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Ellen |
Bloom |
|
|
|
Eugene |
Kimmelman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
S 2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007.
Issues related to the Sunshine Act.
Issues related to comparative effectiveness.
Issues related to drug import safety.
Issues related to the 1-800 petition for drug ads.
Issues related to the FDA budget.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Agency for Health Care Policy & Research
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Baker-Branstetter |
|
|
|
Ellen |
Bloom |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TEC
16. Specific lobbying issues
Issues related to the media ownership rules.
Issues related to cable prices.
Issues related to the DTV transition.
Issues related to public open airwaves.
Issues related to video competition.
Issues related to phone records privacy.
Issues related to net neutrality.
Issues related to low power FM radio stations.
Issues related to FISA.
Issues related to early termination fees.
Issues related to affordable broadband.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Communications Commission (FCC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Eugene |
Kimmelman |
|
|
|
Joel |
Kelsey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |